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Globally, maternal hypertensive disorders in pregnancy significantly increase both maternal and 
perinatal morbidity and mortality. Maternal hypertension affects 14 percent of pregnancies. 
Eearly detection and management are critical for improving the health outcomes of both mother 
and neonate.  
 
Objective 
To assess the association between maternal hypertension disorders in pregnancy and immediate 
neonatal outcomes at a University Teaching Hospital in Rwanda.  
 
Methods 
A retrospective study of maternal files with hypertension disorders was conducted from January 
1, 2016, to March 31, 2019. A census sample of 114 records and pretested checklist was used 
to collect data. Descriptive statistics were used to analyze associations between maternal factors 
and immediate neonatal outcomes. 
 
Results 
Neonatal outcomes included low birth weight (75.4%), prematurity (59.6%), admission to 
neonatal intensive care unit (50.4%), intrauterine growth restriction (32.4%), and neonatal death 
(22.8%). Nearly two-thirds (62%) of mothers had preeclampsia. Significant associations with 
immediate neonatal outcomes included gestational age, medical history, delivery mode, maternal 
referral status, preterm birth, prematurity, and abortion. 
 
Conclusion 
Maternal hypertensive disorders were significantly associated with adverse neonatal outcomes 
in our study population in Rwanda. Improving early detection, health education, and 
management of hypertensive disorders in pregnancy is critical to reduce maternal and neonatal 
morbidity and mortality.  
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Globally, maternal and perinatal morbidity and 
mortality due to maternal hypertension in 
pregnancy is a significant public health threat in 
low-and middle-income countries (LMIC) and high-
income countries.[1] A systematic review of 115 
countries worldwide revealed that 14% of all 
maternal mortality was due to hypertensive 
pregnancy disorders, amounting to 42,000 deaths 
annually.[1,2] Furthermore, almost 1 in 5 (17.9%) 
hypertensive women had a stillbirth or neonatal 
death in a study in sub-Sahara Africa (SSA), India, 
and Haiti.[3] 
 
Maternal hypertensive disorders are more likely to 
cause significant adverse perinatal outcomes in 
LMIC. It is estimated that 2.6 million stillbirths 
occur each year, and 98% occur in LMIC.[4] Other 
serious neonatal outcomes from maternal 
hypertension include prematurity, low birth weight 
(LBW), intrauterine fetal demise (IUFD), intrauterine 
growth restriction (IUGR), respiratory distress, 
admission at neonatal intensive care unit (NICU), 
and neonatal death.[5] 
 
Hypertension in pregnancy is defined as either a 
systolic blood pressure (BP) of ≥140 mm Hg OR a 
diastolic ≥90 mm Hg.[6] Maternal hypertensive 
disorders are classified into four types: Chronic 
hypertension, that is known before pregnancy, or 
present in the first 20 weeks. New onset of 
hypertension that develops at or after 20 weeks 
gestation includes preeclampsia superimposed on 
chronic hypertension, preeclampsia, and eclampsia 
and gestational hypertension.[6] Among these four 
hypertensive disorders, preeclampsia and 
eclampsia have the most significant effects on 
maternal and newborn morbidity and mortality.[6] 
However, timely and effective interventions using 
evidence-based practice could prevent morbidity 
and mortality.[7]  
 
Numerous studies are addressing hypertensive 
disorders in pregnancy. A systematic review and 
meta-analysis of 55 studies in the United States [6] 
reported pregnant women (n=795 221) with chronic 
hypertension had a higher incidence of 
superimposed preeclampsia (25.9%), a cesarean 
delivery (41.4%), preterm birth at 37 weeks or less 
(28.1%) of <2500 grams (16.9%) NICU care (20.5%) 
and perinatal death (4.0%).[8] 
 
In SSA, perinatal loss rates are higher than in high-
income countries. In South Africa, a prospective 
study of pregnant women (n=1547) with 
preeclampsia at three tertiary facilities, had 1589 
births (including 42 twins), revealed a 21% perinatal 
mortality rate, and of this 84.5% were stillbirths.[9] 
Of the live births (n=1308), 70.0% were born 
preterm (<37 weeks), and of those, 41.7% were born 
at <34 weeks' gestation.[9] In Southern Ethiopia, a 
retrospective study of women (n=7347) hospitalized 
with a hypertensive disorder reported a 49% 
preterm birth rate.[9] In Uganda, a cross-sectional 
study compared adverse neonatal outcomes with 
good neonatal outcomes, and found pregnant 
women with preeclampsia were nearly six times 
more likely to have a preterm birth (OR 5.97).[10] 
 
The Rwanda Demographic Health Survey (RDHS), 
2014-2015 showed that neonatal and post-neonatal 
mortality rates were at 20 deaths per 1,000 live 
births and 13 deaths per 1,000 live births, 
respectively.[11] The perinatal mortality rate was 29 
deaths per 1,000 pregnancies.[11] 
 
Since maternal hypertensive disorders are a 
significant public threat to both mother and 
newborn, a study was undertaken to identify the 
existing situation of neonatal outcomes in Rwanda.  
Neonatal outcomes are commonly cited in the 
perinatal literature; however, the outcome has not 
been reported concerning the mother's hypertensive 
disorder in many cases. A specific look at the 
University Teaching Hospital of Butare (CHUB) 
revealed a high incidence of hypertensive disorders, 
with about 7.6 cases per month among the 350 
patients admitted.[12] The scarcity of evidence 
about this area of study in Rwanda inspired the 
investigator to assess the neonatal outcome of 
mothers with hypertensive disorders to improve the 
management of neonates by reducing fetal and 
neonatal mortality through timely delivery and 
appropriate care. This study aimed to identify 
immediate outcomes of neonates from mothers with 





A descriptive retrospective study design of mothers' 
records and files was used to determine neonates' 
immediate outcomes from mothers who had 
hypertension during pregnancy. The study site was 









A purposive strategy and a census sampling method 
(also known as complete enumeration) were used. 
Data were collected from all available patients' files 
delivered by mothers with hypertensive disorders 
during the study period from January 1, 2016, to 
March 31, 2019. A total of 114 neonates were 
eligible and selected for the study. All neonates 
delivered by mothers with hypertensive disorders 
and included: chronic HTN, preeclampsia 
superimposed on chronic HTN, preeclampsia and 
eclampsia, and gestational HTN (hypertension). 
 
Measures 
The checklist was developed from the published 
literature and included the conceptual framework 
for adverse birth outcomes developed by Olusanya 






Figure 1: Study conceptual Framework for neonatal Birth Outcomes adapted Olusanya 
and Ofovwe, 2010 p.409-415)*. [12] 
 








The checklist consisted of three parts: 
The first part comprised of sociodemographic 
characteristics (4 items). Gestational age (abortion 
[<20 weeks], preterm [<37.6 weeks], term [≥ 38 
weeks]). Medical history: HTN (chronic HTN; 
preeclampsia superimposed on chronic HTN; 
preeclampsia and eclampsia; gestational HTN); 
IUFD; and other conditions. Mode of delivery 
(spontaneous vaginal delivery [SVD] or Cesarean 
delivery) maternal referral. Variables were 
presented in frequencies 
 
The second part comprised of the neonatal 
parameters and status (10 items), and included 
congenital malformation; IUGR; neonatal weight (< 
2500 grams, 2500-4000 g); NICU admission; 
meconium aspiration syndrome; transient 
tachypnea of the newborn (TTN); respiratory 
distress (mild, moderate and severe); neonatal 
demise (death, no death); APGAR at 1, 5, and 10 
minutes. The Apgar classification of asphyxia at 10 
min was mild (5-6), moderate (4-3), and severe (2-
0). Variables were scored as frequencies.  
 
The third part was composed by  neonatal outcomes 
(five items) and included gestational age, neonate 
birth weight, asphyxia, NICU admission, and 
neonatal death. Chi-square was used to identify 
associations 
 
The data collection checklist was pretested on ten 
maternal patients' files to test for the feasibility of 
the study, and these files were not included in the 
final data. The results of this pretest suggested, 
minor correction, of the checklist before final data 
collection. Items that were removed included the 
item on antenatal booking, maternal occupation, 
and educational attainment, as these items were 
not documented in patients' files. 
 
Data collection 
The data were collected by the investigator and two 
well-trained research assistants (RA). The 
investigator and RAs visited the hospital archives 
and selected the patients' numbers corresponding 
to the mothers' records with hypertensive disorders. 
All retrieved files were kept alone for the exploration 
of neonates and maternal parameters. 
 
Data analysis 
The data collected were coded and entered into 
SPSS, version 21. Descriptive statistics such as 
mean, standard deviation, and frequencies tables 
were used to summarize the data. Chi-square test 
was used to assess the association between 
maternal factors sociodemographic variables with 
the neonatal outcome parameters of prematurity, 
asphyxia, NICU admission, and neonatal death. The 
significance was set at p<0.05.  
 
Ethical considerations 
The Institutional Review Board, of the College of 
Medicine and Health Sciences, at the University of 
Rwanda, approved the study. Also, the CHUB 
Research and Ethics Committee granted 
permission to use archives and collect the data. We 
used individual patient numbers/codes to ensure 




This retrospective study assessed the immediate 
neonatal outcomes among 114 mothers with 
hypertensive disorders in pregnancy during a thirty-
nine-month data collection period. The maternal 
























Table 1. Maternal sociodemographic characteristics (n=114) 
____________________________________________ 
Characteristics    n (%) 
___________________________________________ 
Mode of delivery 
SVD     59 (51.8) 
Cesearean    55 (48.2) 
Past Medical History 
HTN     39 (34.2) 
IUFD     19 (16.7) 
Other     56 (49.1) 
Maternal Referral^(n=102) 
Yes      31 (30.4) 
No     71 (69.6) 
___________________________________________ 
^ Missing data 
 
The sociodemographic characteristics of the mothers indicated that over half (51.8%) had a SVD, and nearly 
half (48.2%) had a cesarean delivery (Table 1). Over one-third (34.2%) had a past medical history of 




Figure 2. Maternal type of HTN disorder 
 
Nearly two thirds (62%) of the mothers had preeclampsia and eclampsia HTN during pregnancy (Figure 1). Other 
types included preeclampsia superimposed on chronic HTN (22%), gestational HTN (14%), and chronic HTN 
(2%). 





Table 2. Immediate parameters and status of neonates 
____________________________________________________ 
Variables      n (%) 
____________________________________________________ 
Newborn 
2500-4000 g     28 (24.6) 
Gestational age 
Abortion     12 (10.5) 
Preterm      68 (59.6) 
Term      34 (29.8)   
IUGR 
Yes       36 (32.4) 
Congenital malformation 
Yes      7 (6.4) 
Meconium aspiration syndrome 
Yes      19 (17.4) 
Respiratory distress 
Mild      15 (13.2) 
Moderate     14 (12.3) 
Severe                14 (12.3) 
TTN      17 (14.9) 
None      54 (47.4) 
Neonatal weight 
<2500 g (LBW)                                             86 (75.6) 
2500-4000 g (Normal)                                28 (24.6) 
NICU admission 
Yes      57 (50.4) 
No      56 (49.6) 
Neonatal death  
Yes      26 (22.8) 




The majority of neonates were premature (59.6%), and term births were a lower proportion (29.8%) (Table 
2). Nearly a third (32.4%) of neonates had IUGR. The APGAR score shows severe asphyxia at 1 min (38.6%), 
5 min (30.7%), and 10 min (28.9%). Neonates with no asphyxia had the following proportions at 1 min 
(34.2%), 5 min (43.9%), and 10 min (50.0%). Over half (50.4%) of neonates were admitted to the NICU, and 
nearly a quarter died (22.8%). 
 
Table 3. APGAR score at three time points (n = 114) 
______________________________________________________________ 
APGAR  1 min  5 min  10 min 
   n (%)  n (%)  n (%) 
______________________________________________________________ 
Asphyxia 
Severe   44 (38.6) 35 (30.7) 33 (28.9)     
Moderate  20 (17.5) 15 (13.1) 10 (8.8) 
Mild    11 (9.7) 14 (12.3) 14 (12.3) 
None   39 (34.2) 50 (43.9) 57 (50.0) 
________________________________________________________________ 
 
The APGAR scores taken immediately after birth are presented in Table 3. The APGAR at 1 min shows that 
nearly a third of neonates had severe asphyxia (30.7%), at 5 min (30.7%), and 10 min (28.9%). Neonates 









Table 4. Significant associations between maternal factors and neonatal outcomes 
____________________________________________________________________________ 
Variables     Yes  No   p-value 
     n (%)  n (%) 
_______________________________________________________________________________ 
Maternal factor  
Referral (n=31) 
Gestational Age 
         Preterm     14 (45.2)  17 (54.8) 
         Term     17 (54.8) 14 (54.8) 0.002** 
 
Neonatal Factors 
Low Birth Weight             
Gestational age 
         Abortion    12 (100.0) 0 (0) 
         Preterm    60 (88.2) 8 (11.8)  0.001* 
         Term     14 (41.2) 20 (58.8) 
Asphyxia         
      Past medical history       
         HTN    16 (41.0) 23 (59.0) 
         IUFD    3 (15.8) 16 (84.2) 0.006** 
   Other    32 (57.1) 24 (42.9) 
      Mode of delivery        
         SVD    19 (32.2) 40 (67.8) 
         Cesarean    32(58.2)          23 (41.8)  0.005** 
NICU Admission 
      Past medical history       
         HTN    16 (41.0) 23 (59.0)  
         IUFD    3 (15.8) 16 (84.2) 0.000*** 
         Other    39 (69.6) 17 (30.4) 
      Mode of delivery         
         SVD    22 (37.3) 37 (62.7) 
         Cesarean   36 (65.5) 19 (34.5) 0.003** 
      Gestational age       
         Abortion    4 (33.3) 8 (66.7) 
         Preterm    43 (63.2) 25 (36.8) 0.006** 
         Term    11 (32.4) 23 (67.6) 
Neonatal Death  
Past Medical History 
          HTN    8 (20.5) 31 (79.5) 
          IUFD    15 (78.9) 4 (21.1) 0.000*** 
          Other    3 (5.4)  53 (94.6)   
      Mode of delivery        
          SVD    23 (39.0) 36 (61.0) 
          Cesarean    3 (5.5)  52 (94.5) 0.000*** 
      Gestational age       
          Abortion   9 (75.0) 3 (25.0) 
          Preterm    14 (20.6)  54 (79.4) 0.000*** 
    Term     3 (8.8)  31 (91.2) 
________________________________________________________________________ 
 
The significant associations between the maternal factors and neonatal outcomes are presented in Table 4
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Maternal referral  
The findings show that referral was the only 
maternal factor that was significantly associated 
with gestational age at birth (p = 0.002). 
Approximately half of the term (54.8%) and preterm 
newborns (45.2%) had a mother with a hypertensive 
disorder, and mothers were referred from district 
hospitals to the University Teaching Hospital of 
Butare. 
 
Neonatal birth weight 
The findings show that LBW was significantly 
associated with gestational age at birth (p = 0.001) 
among a mother who had a hypertensive disorder. 
The majority (88.2%) of preterm newborns and 




Two variables were significantly associated with 
asphyxia, including maternal medical history (p = 
0.006) and mode of delivery (p = 0.005). Newborns 
whose mothers had a past medical history of HTN 
(41%), an IUFD (15.8%), and other conditions 
(57.1%) had asphyxia. Furthermore, nearly a third 
(32.2%) of SVD births and over half (58.2%) of 
cesarean deliveries were diagnosed with asphyxia 
around the time of birth. 
    
NICU Admission 
Three variables were significantly associated with 
NICU admissions, and include maternal medical 
history (p = 0.001), delivery mode (p = 0.003), and 
gestational age (p = 0.006). Newborns whose 
mothers had a past medical history of HTN (41.0%), 
IUFD (15.8%), and other conditions (69.6%) were 
associated with NICU admissions. Also, two thirds 
(65.5%) of cesarean deliveries and preterm births 




Three variables were significantly associated with 
neonatal death, and include maternal medical 
history, (p = 0.000) mode of delivery (p = 0.000), 
gestational age (p = 0.001). Newborns whose 
mothers had a past medical history of HTN (20.5%), 
IUFD (78.9%), and other conditions (5.4%) were 
associated with neonatal death. Also, over one third 
(39.0%) of SVD births and nearly a quarter (20.6%) 
of preterm newborns were significantly associated 




This retrospective study assessed the 
association between the immediate outcomes 
of 114 neonates whose mothers had 
experienced a hypertension disorder during 
pregnancy. Five neonatal outcomes; 
gestational age, neonate birth weight, 
asphyxia, NICU admission, and neonate death 
were assessed for associations with maternal 
hypertension.  
 
Immediate parameters and status of 
neonates  
The analysis of neonates’ parameters showed that 
the APGAR scores revealed that 50% of neonates 
had asphyxia, and 50.4% were admitted to NICU. In 
addition, 75.4% had LBW and 22.8 % died. Similar 
findings have been reported in many studies where 
was common and many neonates died that were 
born to mothers with hypertension. The same study 
further reported an APGAR score below 7 among 
38.6% of neonate at 5 min, indicating asphyxia.[14-
16] 
 
The study done in Ethiopia [17] showed that still 
birth, LBW, abortion, preterm birth and low APGAR 
score were the most neonatal outcomes in mothers 
with hypertension most common neonatal outcomes 
disorders. Abortion and preterm delivery were into 
the proportions of 10.7% and 31.4% respectively. 
Similar studies from both LMIC and high-income 
countries also revealed that children from mothers 
with hypertension disorders had an increased risk 
for admission to the NICU as compared with 
children from normotensive mothers. Also, our 
findings concur with those from another study  in 
Saudi Arabia [18] on the prevalence, risk factors, 
and fetal and maternal outcomes of mothers with 
hypertensive disorders of pregnancy . 
 The study concluded that there was a higher 
number of preterm, IUGR and SGA babies among 
the infants from hypertensive mothers. The same 
study further suggested that pregnancy induced 
hypertension (PIH) or hypertensive disorders are one 
of the most common causes of both maternal and 
neonatal morbidity.[18]  
 
Outcomes of neonates and associated maternal 
factors. 
In this study, past medical history of hypertension 
shows a strong association with the NICU admission 
(P-value: 0.001<0.05), neonate asphyxia (P-value: 
0.006<0.05), neonate death (P-value: 0.001<0.05). 
Other factors that show a linkage with the 
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admission include gestational age and mode of 
delivery (P-values: 0.006, and 0.003 respectively), 
they both show a significant association with 
neonatal death (P-value: 0.001<0.05). 
 
Many studies reported that hypertension during 
pregnancy increases the risk of maternal and 
perinatal, morbidity and mortality.[5-7] Comparable 
findings were observed in a study from Queen 
Elizabeth Central Hospital (QECH) neonatal ward 
records where 36.5% of neonates admitted in the 
ward from April to September 2012 had birth 
asphyxia.[21]   
A study by Ahmed and colleagues revealed a 
frequency of perinatal asphyxia varied from 9% to 
22% in different studies.[22] In this study, delivery 
mode was also linked with birth asphyxia (P-value: 
0.005<0.05). Likewise, Kibitui found out that 
linkage and the association between those two 
variables was strong.[23] It is also important to 
remember that in the management of hypertensive 
disorder, an emergency caesarean section must be 
done to save maternal and foetal life. This has also 
implication for NICU admission since the baby may 
have, LBW, IUGR, prematurity, low APGAR score 
(<7) and birth asphyxia as was observed in half of 
our study sample group. Asphyxia also predisposes 
neonates to death. Our results about gestational age 
are in support with the findings from a Tertiary Care 
Centre from India which concluded that 54.67% 
neonates born to hypertensive mothers were low 
birth weight and over 63% newborn were preterm.[3] 
Another study mentioned that the cause of neonatal 
mortality is due to prematurity and LBW, and that 
NICU admissions and duration of stay was high.[24] 
Some hospital based prospective and retrospective 
studies from Nepal and Ethiopia showed that 
respective proportions of 13% and 30.2 % of babies 
were delivered premature.[25] These are in line with 
our findings, though reported proportions of 
prematurity were comparatively low. This 
discrepancy resides in the methods and enrolled 
pregnant women into research studies. 
 
In our study, hypertension disorders were mainly 
preeclampsia, eclampsia and chronic hypertension. 
This has also been the reason for the high 
proportion in neonatal outcomes as compared to 
other studies.[25,26]  
 
Limitations  
There are two main limitations to this study that 
could be addressed in future research. First, the 
method used in this study was retrospective; 
therefore, we were limited to the data previously 
collected, and some of the data on the quality of care 
given to neonates was missing from the files. 
Secondly, there was a small sample size due to the 
time constraint of data collection.  
 
Recommendations 
We recommend early recognition and ‘best time to 
deliver management and treatment of hypertensive 
disorders.  We recommend reducing neonatal 
deaths due to birth asphyxia through quality service 
improvement in maternity and neonatology 
departments. Significant efforts should be directed 
to close monitoring and management of mothers 
with hypertensive disorders to save the lives of 
mothers, fetuses, and neonates. Moreover, maternal 
and child HCPs at all levels need to identify women 
at risk, by optimizing management of pre-existing 
maternal medical conditions such as hypertension, 
diabetes, and obesity; and offer counseling, closer 
monitoring, and refer as needed to a hospital for 
antihypertensive medications that are considered 
safe in pregnancy.  WHO recommends calcium 
supplementation before pregnancy for the 
prevention of preeclampsia and its 
complications.[27] This combined effort may, in 
turn, reduce the maternal and neonatal morbidity 
and mortality associated with preeclampsia and 




This retrospective study of a population at a referral 
hospital in Rwanda demonstrated that there is a 
relationship between maternal hypertensive 
disorders and neonatal outcomes. Neonatal adverse 
events such as asphyxia, LBW, prematurity, IUGR, 
NICU admission, and neonatal death were more 
prevalent if the mother had a hypertensive disorder 
during pregnancy. Additional studies are needed to 
understand the causal pathways that may cause 
disordered fetal development in preeclampsia, as 
well as the adult disease processes a future study is 
needed in predisposing factors of developing 
gestational hypertension in women who use ≥800 
µg/d FA as a supplement during pregnancy. 
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